Surrozen advances diabetic macular edema candidate into clinic after IND clearance

RegulatoryapprovedPositive

AI Analysis

Summary

Surrozen has received IND clearance to advance its diabetic macular edema candidate into clinical trials. The company is now authorized to initiate clinical development of the investigational therapy.

Clinical Trial Data

Phase

Phase 1

Outcome Details

IND clearance received

Importance:5/10

Sentiment:

0.70

IND clearancediabetic macular edemaclinical development

Read the original article

Published by Seeking Alpha Healthcare on October 2, 2026 12:45 PM

Read Original